ROVESTI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.327
AS - Asia 1.326
EU - Europa 1.260
SA - Sud America 194
AF - Africa 43
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.168
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.254
IT - Italia 487
SG - Singapore 403
CN - Cina 344
VN - Vietnam 196
GB - Regno Unito 182
BR - Brasile 145
HK - Hong Kong 144
DE - Germania 106
SE - Svezia 92
FI - Finlandia 70
RU - Federazione Russa 65
FR - Francia 57
IE - Irlanda 47
CA - Canada 39
KR - Corea 36
ID - Indonesia 35
IN - India 29
JP - Giappone 23
NL - Olanda 23
MX - Messico 21
TR - Turchia 21
BD - Bangladesh 20
BE - Belgio 20
AR - Argentina 18
UA - Ucraina 18
AU - Australia 16
IQ - Iraq 16
BG - Bulgaria 15
AL - Albania 14
ES - Italia 14
ZA - Sudafrica 11
AT - Austria 10
PK - Pakistan 10
CO - Colombia 9
PL - Polonia 8
CZ - Repubblica Ceca 7
MY - Malesia 7
AE - Emirati Arabi Uniti 6
CL - Cile 5
EC - Ecuador 5
KE - Kenya 5
LT - Lituania 5
MA - Marocco 5
AZ - Azerbaigian 4
EG - Egitto 4
NG - Nigeria 4
NP - Nepal 4
TN - Tunisia 4
VE - Venezuela 4
BO - Bolivia 3
BY - Bielorussia 3
BZ - Belize 3
CH - Svizzera 3
IR - Iran 3
JM - Giamaica 3
OM - Oman 3
PE - Perù 3
RO - Romania 3
RS - Serbia 3
SA - Arabia Saudita 3
SI - Slovenia 3
TW - Taiwan 3
UZ - Uzbekistan 3
BW - Botswana 2
CR - Costa Rica 2
DZ - Algeria 2
GE - Georgia 2
KZ - Kazakistan 2
PA - Panama 2
PT - Portogallo 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
CI - Costa d'Avorio 1
CM - Camerun 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GH - Ghana 1
GR - Grecia 1
HR - Croazia 1
JO - Giordania 1
LK - Sri Lanka 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MQ - Martinica 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
TH - Thailandia 1
UY - Uruguay 1
Totale 5.168
Salva come PNG Salva come JPEG
Città #
Singapore 278
Ashburn 272
Santa Clara 260
Fairfield 185
Chandler 145
Hong Kong 133
San Jose 98
Houston 88
Modena 80
Hefei 77
Wilmington 76
Southend 75
Seattle 73
Woodbridge 72
Nyköping 65
Beijing 64
Cambridge 60
Ann Arbor 59
Bologna 59
Helsinki 58
Council Bluffs 57
London 57
New York 52
Ho Chi Minh City 51
Los Angeles 47
Dublin 46
Hanoi 44
The Dalles 41
Munich 34
Seoul 34
Milan 33
Jakarta 30
Dearborn 29
Dallas 24
Jacksonville 23
San Diego 22
Chicago 19
Orem 19
Reggio Emilia 19
Toronto 18
Bremen 16
Brussels 16
Fremont 16
Shanghai 16
Buffalo 15
Princeton 15
Sofia 15
Florence 14
Lauterbourg 14
Moscow 14
Da Nang 13
Frankfurt am Main 13
Boardman 12
Brooklyn 11
Guangzhou 11
San Giuliano Milanese 11
São Paulo 11
Dong Ket 10
Tirana 10
Turku 10
Haiphong 9
Mumbai 9
Tokyo 9
Adelaide 8
Chennai 8
Eugene 8
Falls Church 8
Hangzhou 8
Mexico City 8
Montreal 8
Phoenix 8
Amsterdam 7
Denver 7
Izmir 7
Parma 7
Redondo Beach 7
Rome 7
Salt Lake City 7
Shinjuku 7
Atlanta 6
Genoa 6
Johannesburg 6
Redwood City 6
Rio de Janeiro 6
Vienna 6
Warsaw 6
Aydin 5
Can Tho 5
Columbus 5
Fidenza 5
Grimes 5
Nuremberg 5
Ottawa 5
Padova 5
Paris 5
Stockholm 5
Vicenza 5
Baghdad 4
Baku 4
Casalecchio Di Reno 4
Totale 3.495
Salva come PNG Salva come JPEG
Nome #
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 417
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 406
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 392
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 373
Axillary Ectopic Carcinoma of the Breast. Report of Two Cases with Different Clinical Presentation and Review of the Literature. 323
Management of adverse events with tailored sorafenib dosing prolongs survival of hepatocellular carcinoma patients 273
1H-NMR based serum metabolomics highlights different specific biomarkers between early and advanced hepatocellular carcinoma stages 273
ANGPT2 and NOS3 Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib 272
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma 240
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 236
TRAIL receptors are expressed in both malignant and stromal cells in pancreatic ductal adenocarcinoma 225
Clinical implications of malnutrition in the management of patients with pancreatic cancer: Introducing the concept of the nutritional oncology board 221
The growing skyline of advanced hepatocellular carcinoma treatment: A review. 203
Immunotherapy: AUTOLOGOUS ANTI-GD2 CAR T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA 191
Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience 159
Chapter 8 - Hybrid polymeric scaffolds for brain applications: locoregional glioblastoma therapy 156
Could inflammatory indices and metabolic syndrome predict the risk of cancer development? Analysis from the bagnacavallo population study 152
Prognostic Role of a New Index (RAPID Index) in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib: Training and Validation Cohort 140
BRCA in Gastrointestinal Cancers: Current Treatments and Future Perspectives 139
Utility of neutrophil-to-lymphocyte ratio to identify long-term survivors among HCC patients treated with sorafenib 137
External validation of surrogate indices of fatty liver in the general population: The Bagnacavallo study 131
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus 123
CAR-T for Lung Cancers: Challenges and Innovations 37
Totale 5.219
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.762
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.762
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021151 0 0 0 0 0 0 0 0 0 62 62 27
2021/2022395 25 36 21 8 26 54 28 25 26 34 81 31
2022/2023494 63 56 28 46 48 48 9 51 85 7 27 26
2023/2024267 8 12 18 28 33 40 9 27 9 17 22 44
2024/20251.291 24 24 61 121 206 212 115 78 151 73 98 128
2025/20261.866 165 64 115 239 285 124 290 105 226 253 0 0
Totale 5.219